The role of BRCA1 in transcriptional regulation and cell cycle control

[1]  S. Kato,et al.  An hGCN5/TRRAP Histone Acetyltransferase Complex Co-activates BRCA1 Transactivation Function through Histone Modification* , 2006, Journal of Biological Chemistry.

[2]  P. Watson,et al.  BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene. , 2005, Cancer research.

[3]  P. Johnston,et al.  The 2,5 oligoadenylate synthetase/RNaseL pathway is a novel effector of BRCA1- and interferon-γ-mediated apoptosis , 2005, Oncogene.

[4]  B. Katzenellenbogen,et al.  Cyclin D1 Antagonizes BRCA1 Repression of Estrogen Receptor α Activity , 2005 .

[5]  B. Chait,et al.  MED1/TRAP220 exists predominantly in a TRAP/ Mediator subpopulation enriched in RNA polymerase II and is required for ER-mediated transcription. , 2005, Molecular cell.

[6]  A. Horwitz,et al.  BRCA1/BARD1 Ubiquitinate Phosphorylated RNA Polymerase II* , 2005, Journal of Biological Chemistry.

[7]  J. Manley,et al.  BRCA1/BARD1 inhibition of mRNA 3' processing involves targeted degradation of RNA polymerase II. , 2005, Genes & development.

[8]  E. Rosen,et al.  Regulation of the estrogen-inducible gene expression profile by the breast cancer susceptibility gene BRCA1. , 2005, Endocrinology.

[9]  Seokjoong Kim,et al.  Tetrameric Oligomerization Mediates Transcriptional Repression by the BRCA1-dependent Kruppel-associated Box-Zinc Finger Protein ZBRK1* , 2004, Journal of Biological Chemistry.

[10]  C. Deng,et al.  A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  C. Moskaluk,et al.  Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor. , 2004, Genes & development.

[12]  Ichiro Takada,et al.  BRCA1 function mediates a TRAP/DRIP complex through direct interaction with TRAP220 , 2004, Oncogene.

[13]  L. Gaudreau,et al.  BRCA1 Can Modulate RNA Polymerase II Carboxy-Terminal Domain Phosphorylation Levels , 2004, Molecular and Cellular Biology.

[14]  Kum Kum Khanna,et al.  BRCA1-BARD1 Complexes Are Required for p53Ser-15 Phosphorylation and a G1/S Arrest following Ionizing Radiation-induced DNA Damage* , 2004, Journal of Biological Chemistry.

[15]  H. Chew,et al.  BRCA1 cooperates with NUFIP and P-TEFb to activate transcription by RNA polymerase II , 2004, Oncogene.

[16]  Zhihui Feng,et al.  DNA Damage Induces p53-dependent BRCA1 Nuclear Export* , 2004, Journal of Biological Chemistry.

[17]  E. Rosen,et al.  BRCA1 Inhibits Membrane Estrogen and Growth Factor Receptor Signaling to Cell Proliferation in Breast Cancer , 2004, Molecular and Cellular Biology.

[18]  E. Liu,et al.  BRCA1 Interacts with and Is Required for Paclitaxel-Induced Activation of Mitogen-Activated Protein Kinase Kinase Kinase 3 , 2004, Cancer Research.

[19]  Wen-Hwa Lee,et al.  Functional Dissection of Transcription Factor ZBRK1 Reveals Zinc Fingers with Dual Roles in DNA-binding and BRCA1-dependent Transcriptional Repression* , 2004, Journal of Biological Chemistry.

[20]  Susan A. Krum,et al.  BRCA1 Associates with Processive RNA Polymerase II* , 2003, Journal of Biological Chemistry.

[21]  T. Stokke,et al.  Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1 , 2003, Oncogene.

[22]  E. Rosen,et al.  BRCA1 Inhibition of Telomerase Activity in Cultured Cells , 2003, Molecular and Cellular Biology.

[23]  Michael B Yaffe,et al.  BRCT Repeats As Phosphopeptide-Binding Modules Involved in Protein Targeting , 2003, Science.

[24]  M. Bosticardo,et al.  IGF-1 down-regulates IFN-γR2 chain surface expression and desensitizes IFN-γ/STAT-1 signaling in human T lymphocytes , 2003 .

[25]  Wen-Hwa Lee,et al.  Degradation of Transcription Repressor ZBRK1 through the Ubiquitin-Proteasome Pathway Relieves Repression of Gadd45a upon DNA Damage , 2003, Molecular and Cellular Biology.

[26]  P. Ongusaha,et al.  BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest , 2003, Oncogene.

[27]  J. Glover,et al.  Structural Consequences of a Cancer-causing BRCA1-BRCT Missense Mutation* , 2003, The Journal of Biological Chemistry.

[28]  H. Kawai,et al.  Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells , 2002, Oncogene.

[29]  Phang-lang Chen,et al.  BRCA1 Facilitates Microhomology-mediated End Joining of DNA Double Strand Breaks* , 2002, The Journal of Biological Chemistry.

[30]  D. Haber,et al.  BRCA1 Regulates the Interferon γ-mediated Apoptotic Response* , 2002, The Journal of Biological Chemistry.

[31]  H. Avraham,et al.  A Novel Tricomplex of BRCA1, Nmi, and c-Myc Inhibits c-Myc-induced Human Telomerase Reverse Transcriptase Gene (hTERT) Promoter Activity in Breast Cancer* , 2002, The Journal of Biological Chemistry.

[32]  W. El-Deiry,et al.  BRCA1 Directs a Selective p53-Dependent Transcriptional Response towards Growth Arrest and DNA Repair Targets , 2002, Molecular and Cellular Biology.

[33]  M. King,et al.  BRCA1 transcriptionally regulates genes involved in breast tumorigenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  E. Williamson,et al.  BRCA1 transactivates the cyclin-dependent kinase inhibitor p27Kip1 , 2002, Oncogene.

[35]  Tong Tong,et al.  BRCA1 Regulates GADD45 through Its Interactions with the OCT-1 and CAAT Motifs* , 2002, The Journal of Biological Chemistry.

[36]  Lawrence C. Brody,et al.  BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage , 2002, Nature Genetics.

[37]  Anne E Carpenter,et al.  BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations , 2001, The Journal of cell biology.

[38]  R. Baer,et al.  Tumour suppressors (Communication arising): Effect of DNA damage on a BRCA1 complex , 2001, Nature.

[39]  E. Liu,et al.  BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents , 2001, Oncogene.

[40]  W. Lee,et al.  BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  G. Li,et al.  Rb-associated protein 46 (RbAp46) inhibits transcriptional transactivation mediated by BRCA1. , 2001, Biochemical and biophysical research communications.

[42]  E. Liu,et al.  BRCA1 Is a Selective Co-activator of 14-3-3ς Gene Transcription in Mouse Embryonic Stem Cells* 210 , 2001, The Journal of Biological Chemistry.

[43]  T. Ohta,et al.  The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation* , 2001, The Journal of Biological Chemistry.

[44]  Bo Xu,et al.  Involvement of Brca1 in S-Phase and G2-Phase Checkpoints after Ionizing Irradiation , 2001, Molecular and Cellular Biology.

[45]  B. Hulka,et al.  Breast cancer: hormones and other risk factors. , 2001, Maturitas.

[46]  M. Erdos,et al.  Role of direct interaction in BRCA1 inhibition of estrogen receptor activity , 2001, Oncogene.

[47]  L. Bégin,et al.  Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  W. El-Deiry,et al.  Repression of BRCA1 through a Feedback Loop Involving p53* , 2000, The Journal of Biological Chemistry.

[49]  P. L. Chen,et al.  Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1. , 2000, Molecular cell.

[50]  P. Quail,et al.  HFR1 encodes an atypical bHLH protein that acts in phytochrome A signal transduction. , 2000, Genes & development.

[51]  H. Mukhtar,et al.  Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. , 2000, Biochemical and biophysical research communications.

[52]  Qimin Zhan,et al.  BRCA1 activation of the GADD45 promoter , 2000, Oncogene.

[53]  Alexander Kinev,et al.  BRCA1 Is Associated with a Human SWI/SNF-Related Complex Linking Chromatin Remodeling to Breast Cancer , 2000, Cell.

[54]  Y. Shiloh,et al.  Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response , 2000, Nature.

[55]  R. Baer,et al.  Nuclear Localization and Cell Cycle-specific Expression of CtIP, a Protein That Associates with the BRCA1 Tumor Suppressor* , 2000, The Journal of Biological Chemistry.

[56]  Mutsuko Ouchi,et al.  Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[57]  H. Ruffner,et al.  CBP/p300 interact with and function as transcriptional coactivators of BRCA1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[58]  W. El-Deiry,et al.  BRCA1 Effects on the Cell Cycle and the DNA Damage Response Are Linked to Altered Gene Expression* , 2000, The Journal of Biological Chemistry.

[59]  B. Weber,et al.  BRCA1 signals ARF-dependent stabilization and coactivation of p53 , 1999, Oncogene.

[60]  B. Koller,et al.  Brca1 controls homology-directed DNA repair. , 1999, Molecular cell.

[61]  M. Erdos,et al.  BRCA1 inhibition of estrogen receptor signaling in transfected cells. , 1999, Science.

[62]  R. Yarden,et al.  BRCA1 interacts with components of the histone deacetylase complex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[63]  C. Osborne,et al.  Binding of CtIP to the BRCT Repeats of BRCA1 Involved in the Transcription Regulation of p21 Is Disrupted Upon DNA Damage* , 1999, The Journal of Biological Chemistry.

[64]  C. Harris,et al.  GADD45 induction of a G2/M cell cycle checkpoint. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[65]  J. Parvin,et al.  Activation of Transcription in Vitro by the BRCA1 Carboxyl-terminal Domain* , 1999, The Journal of Biological Chemistry.

[66]  N. Shao,et al.  The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter , 1999, Oncogene.

[67]  D. Levy,et al.  Differential viral induction of distinct interferon‐α genes by positive feedback through interferon regulatory factor‐7 , 1998, The EMBO journal.

[68]  Sean V Tavtigian,et al.  Characterization of a carboxy-terminal BRCA1 interacting protein , 1998, Oncogene.

[69]  Hongtao Zhang,et al.  BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells , 1998, Oncogene.

[70]  A. Bowcock,et al.  The C-terminal (BRCT) Domains of BRCA1 Interact in Vivo with CtIP, a Protein Implicated in the CtBP Pathway of Transcriptional Repression* , 1998, The Journal of Biological Chemistry.

[71]  J. Parvin,et al.  BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A , 1998, Nature Genetics.

[72]  J. M. Boyd,et al.  Interaction between a Cellular Protein That Binds to the C-terminal Region of Adenovirus E1A (CtBP) and a Novel Cellular Protein Is Disrupted by E1A through a Conserved PLDLS Motif* , 1998, The Journal of Biological Chemistry.

[73]  Hui Tian,et al.  BRCA1 physically associates with p53 and stimulates its transcriptional activity , 1998, Oncogene.

[74]  Y. Houvras,et al.  Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl , 1997, Nature.

[75]  B. Howard,et al.  WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases , 1997, Molecular and cellular biology.

[76]  F. Collins,et al.  Human BRCA1 inhibits growth in yeast: potential use in diagnostic testing. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[77]  R. Young,et al.  BRCA1 is a component of the RNA polymerase II holoenzyme. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[78]  Peer Bork,et al.  A superfamily of conserved domains in DNA damage‐ responsive cell cycle checkpoint proteins , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[79]  Anne M. Bowcock,et al.  Identification of a RING protein that can interact in vivo with the BRCA1 gene product , 1996, Nature Genetics.

[80]  H. Hanafusa,et al.  Evidence for a transcriptional activation function of BRCA1 C-terminal region. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[81]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.